医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

Reddy’s Laboratories Announces the Launch

Dr. Reddy’s Laboratories Announces the Launch of Propofol Injectable Emulsion, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Propofol Injectable Emulsion, USP in the U.S. Market

ヘルスケア製薬　 TimeLine: Reddy's Laboratories Announces the Launch USP in the U.S

2019年01月24日

0

Dr. Reddy’s Laboratories Announces the Launch of Sevelamer Carbonate for Oral Suspension in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Sevelamer Carbonate for Oral Suspension in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: for Oral Suspension in the U.S Reddy's Laboratories Announces the Launch

2018年12月27日

0

Dr. Reddy’s Laboratories Announces the Launch of Chlorthalidone Tablets, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Chlorthalidone Tablets, USP in the U.S. Market

ヘルスケアヘルス一般心臓学製薬　 TimeLine: Reddy's Laboratories Announces the Launch USP in the U.S

2018年11月28日

0

Dr. Reddy’s Laboratories Announces the Launch of Atomoxetine Capsules, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Atomoxetine Capsules, USP in the U.S. Market

ヘルスケアヘルス一般臨床試験製薬　 TimeLine: Reddy's Laboratories Announces the Launch USP in the U.S

2018年10月31日

0

Dr. Reddy’s Laboratories announces the launch of Colesevelam Hydrochloride Tablets in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Colesevelam Hydrochloride Tablets in the U.S. Market

ヘルスケア製薬　 TimeLine: Hydrochloride Tablets in the U.S Reddy's Laboratories Announces the Launch

2018年10月09日

0

Dr. Reddy’s Laboratories Announces the Launch of Imatinib Mesylate Tablets, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Imatinib Mesylate Tablets, USP in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Reddy's Laboratories Announces the Launch USP in the U.S

2018年10月01日

0

Dr. Reddy’s Laboratories Announces the Launch of Neostigmine Methylsulfate Injection, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Neostigmine Methylsulfate Injection, USP in the U.S. Market

ヘルスケアヘルス一般製薬　 TimeLine: Methylsulfate Injection Reddy's Laboratories Announces the Launch USP in the U.S

2018年09月12日

0

Dr. Reddy’s Laboratories Announces the Launch of Hervycta® (trastuzumab biosimilar) in India

Dr. Reddy’s Laboratories Announces the Launch of Hervycta® (trastuzumab biosimilar) in India

バイオテクノロジーヘルスケアヘルス一般腫瘍学製薬　 TimeLine: Reddy's Laboratories Announces the Launch Trastuzumab Biosimilar

2018年07月26日

0

Dr. Reddy’s Laboratories Announces the Launch of Hydroxychloroquine Sulfate Tablets, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Hydroxychloroquine Sulfate Tablets, USP in the U.S. Market

ヘルスケアヘルス一般製薬　 TimeLine: Reddy's Laboratories Announces the Launch Sulfate Tablets USP in the U.S

2018年07月11日

0

Dr. Reddy’s Laboratories Announces the Launch of Levetiracetam in Sodium Chloride Injection in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Levetiracetam in Sodium Chloride Injection in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Reddy's Laboratories Announces the Launch Sodium Chloride Injection in the U.S

2018年06月19日

0